In March 2012, leading members of the respiratory care community attended a Summit entitled “Respiratory Care 2020: High Quality, Low Carbon” . The meeting identified priority areas for action to improve the environmental sustainability of respiratory services.
The Institute for Government held a policy reunion of the key players that were involved in policies to reduce tobacco use in England, which lead to the enactment of the ban on smoking in public places in 2005.
The first meeting of the Sustainable Respiratory Care programme: a diverse group (including respiratory physicians, GPs, nurses, academics, industry representatives, commissioners and sustainability experts) identified priority areas for action in care for patients with COPD.
Value in healthcare is a recent concept which is being adopted by commissioners and healthcare leaders to focus on treatments which really make an impact to patients, whilst being delivered in an efficient way.
Costing healthcare is a complex area, and carbon costing is becoming more and more relevant. Read on to find out a little more about how the Centre for Sustainable Healthcare is looking to help commissioners define value in respiratory care.
In February 2011 GlaxoSmithKline and the Cooperative Pharmacy in partnership with TerraCycle UK launched the first respiratory inhaler recycling programme in Europe. Forty Cooperative pharmacies across South Wales and the South East of England were piloting the programme for an initial six months. While the pharmacies encouraged patients to drop off their inhalers at their branch, TerraCycle UK recycled every element of the inhaler. After proving a huge success, the project was extended to 200 Cooperative pharmacies from November 2011.
SAP is a programme to support clinical teams in taking action for sustainability. Structured around two facilitated workshops, SAP helps front-line staff to learn about sustainable healthcare, focus in on their priorities and put together a green action plan. The action plan can then
This toolkit gives you everything you need for a 1 minute, 5 minute and even more minute conversation, complete with step-by-step guides, behavioural change insights and all the evidence to back it up.
Section 8.6 of the new BTS/SIGN Guideline for the management of asthma highlights the environmental impact of metered dose inhalers (pMDI) and recommends that inhalers with low global-warming potential (GWP) should be used when likely to be equally effective.